Industries · Pharma & Life Sciences

Cold chain · traceability · channel settlement · GxP-grade audit.

For pharmaceutical manufacturers, distributors, and cross-border cold-chain operators where batch, temperature, and chain-of-custody integrity is not optional.

Pharma and life-science cold-chain logistics fail silently long before they fail visibly — a single temperature excursion or batch traceability gap can trigger a regulatory event. NiuX TMS was deployed at Hayao Group (one of China's largest pharmaceutical operators) for exactly this reason: the same platform carries warehouse batch records, in-transit temperature monitoring, channel settlement, and auditor-ready evidence.

Challenges

The real constraints in pharma & life sciences

Written from an operator's perspective, not a consulting framework.

01

Temperature-chain continuity from warehouse to last mile

Most TMS systems treat temperature as an afterthought; under GxP (or local equivalents in KSA, UAE, LatAm), temperature excursions must be captured, time-stamped, and tied to the specific batch that was affected.

02

Batch / lot / expiry control across WMS → TMS handoff

The handoff between warehouse and transportation is the most common place batch traceability is lost. Operators end up reconstructing batch history manually during audit.

03

Channel mix — B2B distributors, retail chains, hospital direct

Different channels have different SLA, documentation, and settlement terms. Running separate systems per channel destroys group-level visibility.

04

Rebates, freight credits, tri-party settlement

Pharma channel finance is structurally complex — rebates, promotional credits, tri-party reconciliation. This is where Finance teams spend their month-ends.

Playbook

How NiuX TMS addresses it

Not feature bullets — the actual operating approach, encoded as platform capability.

01

Batch / expiry / temperature as first-class citizens

WMS and TMS share batch master data; batch, expiry, and temperature travel with the shipment from warehouse to delivery. Temperature and time excursions trigger near-real-time alerts with a full audit trail.

02

One fulfillment model across channels

B2B distribution, retail direct, and hospital direct share one order and dispatch model; channel differences are configuration, not separate products. Group leadership gets a single dashboard.

03

Rebates and settlement as rules

BMS carries channel rebates, freight credits, and tri-party settlement as configurable rules. Business data and finance data share one source — month-end reconciliation happens on documents, not spreadsheets.

04

Auditor-ready by default

75+ business-event types are captured natively. Financial journals can be traced back to the originating business document, dispatch event, and temperature reading — including regulator audits.

Markets

Where we see pharma & life sciences operators most

This maps to our overseas pipeline — not to an aspirational map of "everywhere we could theoretically sell."

Greater China + APAC

GxP-grade pharma deployments across commercial and group operations (see Hayao Group case studies).

Middle East

Cold-chain modernization for state-sponsored pharma and distribution networks with local-language field operations.

Southeast Asia

Regional distributors modernizing hospital-direct and retail-chain logistics under local regulatory regimes.

Case studies

Pharma & Life Sciences customers on NiuX TMS

Each story includes a company profile for international readers who may not know the buyer by name.

See all customer stories →
Food & Beverage

Want Want Group standardizes transport across 34 bases and 76 factories on NiuX TMS

Want Want China Holdings: Want Want Group (HKEX: 0151.HK) is one of Asia's largest consumer food and beverage manufacturers, best known for rice crackers, dairy drinks, and packaged snacks. The group operates 34 production bases and 76 factories across China, supplying tens of thousands of SKUs to modern trade, traditional wholesale, and e-commerce channels.

Greater China · APAC 4 min read
Pharmaceutical

Hayao Pharmaceutical Headquarters digitizes nationwide distribution on NiuX TMS

Harbin Pharmaceutical Group — Pharmaceutical Manufacturing Headquarters: Harbin Pharmaceutical Group (SSE: 600664), commonly known as Hayao, was the first publicly-listed pharmaceutical company in China. Its Pharmaceutical Manufacturing Headquarters is the group's core industrial production entity, running drug manufacturing that supplies distributors, hospitals, and pharmacies across the country. Hayao owns five China Well-Known Trademarks including Hayao, Sanjing, and Gaizhonggai.

Greater China 4 min read
Pharmaceutical

Hayao Group brings intelligent dispatch to pharmaceutical distribution — the deployment that started it all

Harbin Pharmaceutical Group (Hayao) — commercial distribution arm: Harbin Pharmaceutical Group (SSE: 600664), branded as Hayao, was the first publicly-listed pharmaceutical company in China and remains a bellwether for the country's pharmaceutical industry. The group's commercial distribution arm runs outbound logistics for the full product portfolio across the country — supplying distributors, hospitals, pharmacies, and e-commerce fulfillment centers.

Greater China 3 min read

Bring your real pharma & life sciences operating problem — we'll show you the platform against it.

15-minute scoped conversation beats a 40-slide vertical deck.